Moderna Inc - 株価

MRNA

170.81

毎日の変更:

6.84%

毎年:

264.59%

価格 日 年
Acadia Pharmaceuticals 21.15 -0.05 -0.24% -56.75%
Acorda Therapeutics 4.19 0.26 6.62% 295.28%
Agios Pharmaceuticals 54.69 -0.35 -0.64% 20.49%
Alnylam Pharmaceuticals 138.88 -0.14 -0.10% 0.29%
Alexion Pharmaceuticals 163.68 6.14 3.90% 58.18%
Amgen 255.71 0.58 0.23% 8.83%
Arrowhead Research 67.65 -0.33 -0.49% 85.09%
Biogen 270.31 -0.13 -0.05% -21.09%
Bluebird Bio 28.28 -1.44 -4.85% -49.24%
BioMarin Pharmaceutical 79.40 0.63 0.80% -10.91%
Esperion Therapeutics 27.02 -0.02 -0.07% -27.97%
Gilead Sciences 66.87 1.10 1.67% -20.38%
GlaxoSmithKline 1,346.40 -2.00 -0.15% -18.92%
GW Pharmaceuticals 218.90 0.09 0.04% 114.08%
Intercept Pharmaceuticals 20.28 -0.27 -1.31% -75.05%
YTE 82.68 -0.52 -0.63% -17.32%
Ionis Pharmaceuticals 40.78 -0.25 -0.61% -25.77%
Mirati Therapeutics 158.19 -5.86 -3.57% 74.41%
Puma Biotechnology 10.07 -0.14 -1.37% 4.35%
Ultragenyx Pharmaceutical 108.72 -0.86 -0.78% 85.62%
Regeneron Pharmaceuticals 502.60 7.96 1.61% -11.64%
Seattle Genetics 145.50 -4.14 -2.77% 6.31%
Sangamo BioSciences 11.48 -0.29 -2.46% 51.25%
Sarepta Therapeutics 71.80 -0.83 -1.14% -39.43%
United Therapeutics 203.73 2.06 1.02% 94.73%
Vertex Pharmaceuticals 219.39 -1.71 -0.77% -18.88%


MRNA:US
資産
現金と同等
売上原価
流動資産
流動負債
負債
EBIT
EBITDA
株当たりのEPS利益
自己資本および準備金
売上総利益
債務の支払利息
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
税引前利益
販売収入
販売および管理費
株式
貿易債権者
貿易債務者